BBNX - Beta Bionics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$21.00
DETAILS
HIGH:
$25.00
LOW:
$14.00
MEDIAN:
$22.00
CONSENSUS:
$21.00
UPSIDE:
77.66%
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | 100.3 | 65.1 | 12.0 | 0.2 |
| Cost of Revenue | 44.7 | 29.2 | 5.7 | 0 |
| Gross Profit | 55.5 | 35.9 | 6.3 | 0.2 |
| Operating Expenses | ||||
| R&D Expenses | 34.8 | 26.2 | 17.9 | 31.4 |
| SG&A Expenses | 92.4 | 55.0 | 24.2 | 33.5 |
| Other Expenses | 0 | 0 | 0 | 1.1 |
| Operating Expenses | 127.2 | 81.1 | 42.2 | 66.0 |
| Operating Income | ||||
| Operating Income | (71.7) | (45.3) | (35.9) | (65.8) |
| Interest Expense | 0 | 0 | 0 | 0.0 |
| Interest Income | 10.9 | 3.9 | 1.8 | 0.2 |
| Profitability | ||||
| EBITDA | (73.2) | (44.1) | (34.6) | (63.4) |
| EBIT | (73.2) | (45.3) | (35.9) | (64.7) |
| Income Before Tax | (73.2) | (54.8) | (44.1) | (64.8) |
| Income Tax Expense | 0.0 | 0 | 0 | 0 |
| Net Income | (73.2) | (54.8) | (44.1) | (64.8) |
| Per Share Data | ||||
| EPS (Basic) | -1.81 | -8.60 | -8.31 | -12.96 |
| EPS (Diluted) | -1.81 | -8.60 | -8.31 | -12.96 |
| Shares Outstanding | 40.5 | 6.4 | 5.3 | 5.0 |
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Current Assets | ||||
| Cash & Cash Equivalents | 31.6 | 30.4 | 26.6 | 27.7 |
| Short-Term Investments | 187.5 | 73.1 | 70.2 | 0 |
| Net Receivables | 19.9 | 12.0 | 4.4 | 0 |
| Inventory | 21.7 | 13.3 | 1.2 | 0 |
| Other Current Assets | 0.1 | 1.1 | 0.3 | 0.2 |
| Total Current Assets | 267.9 | 132.9 | 103.6 | 28.5 |
| Non-Current Assets | ||||
| Property, Plant & Equipment | 15.2 | 11.4 | 6.2 | 6.9 |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Long-Term Investments | 45.4 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.2 | 5.3 | 0.2 | 0.2 |
| Total Non-Current Assets | 60.8 | 16.7 | 6.4 | 7.1 |
| Total Assets | 328.7 | 149.6 | 110.0 | 35.5 |
| Current Liabilities | ||||
| Account Payables | 5.0 | 2.9 | 1.2 | 0.4 |
| Short-Term Debt | 0 | 0 | 0 | 0 |
| Deferred Revenue | 1.6 | 0.9 | 0 | 0 |
| Other Current Liabilities | 14.6 | 10.9 | 1.1 | 1.3 |
| Total Current Liabilities | 30.9 | 21.1 | 10.6 | 8.9 |
| Non-Current Liabilities | ||||
| Long-Term Debt | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.5 | 44.9 | 37.8 | 10.5 |
| Total Non-Current Liabilities | 10.2 | 52.5 | 40.8 | 13.7 |
| Total Liabilities | 41.1 | 73.6 | 51.4 | 22.5 |
| Stockholders' Equity | ||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (369.9) | (296.7) | (229.7) | (185.6) |
| Accumulated Other Comprehensive Income | 0.4 | 0.1 | 0.1 | 0 |
| Total Stockholders' Equity | 287.6 | 76.0 | 58.6 | 13 |
| Total Liabilities & Equity | 328.7 | 149.6 | 110.0 | 35.5 |
| Debt Metrics | ||||
| Total Debt | 7.3 | 7.3 | 4.2 | 4.1 |
| Net Debt | (24.3) | (23.2) | (22.3) | (23.5) |
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | (73.2) | (54.8) | (44.1) | (64.8) |
| Depreciation & Amortization | 2.9 | 2.3 | 2.1 | 2.1 |
| Stock-Based Compensation | 16.4 | 6.4 | 5.7 | 6.1 |
| Change in Working Capital | (9.0) | (12.1) | (6.4) | (2.8) |
| Other Non-Cash Items | 12.0 | 10.0 | 10.3 | (0.9) |
| Operating Cash Flow | (50.9) | (48.3) | (32.4) | (60.2) |
| Investing Activities | ||||
| Capital Expenditure | (5.3) | (3.4) | (0.4) | (0.8) |
| Acquisitions | 0 | 0 | 0 | 0 |
| Purchases of Investments | (327.5) | (72.1) | 0 | 0 |
| Sales/Maturities of Investments | 170 | 72 | 0 | 0 |
| Other Investing Activities | 0 | 0.1 | (69.3) | 0.0 |
| Investing Cash Flow | (162.8) | (3.5) | (69.7) | (0.8) |
| Financing Activities | ||||
| Net Debt Issuance | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 101.0 | 0.4 |
| Financing Cash Flow | 214.9 | 55.6 | 101.0 | 56.8 |
| Cash Position | ||||
| Net Change in Cash | 1.1 | 3.9 | (1.1) | (4.2) |
| Cash at Beginning | 30.5 | 26.7 | 27.8 | 32.0 |
| Cash at End | 31.7 | 30.5 | 26.7 | 27.8 |
| Free Cash Flow | (56.2) | (51.7) | (32.8) | (61.0) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 100.3 | 65.1 | 12.0 | 0.2 |
| Gross Profit | 55.5 | 35.9 | 6.3 | 0.2 |
| Operating Income | (71.7) | (45.3) | (35.9) | (65.8) |
| Net Income | (73.2) | (54.8) | (44.1) | (64.8) |
| EPS (Diluted) | -1.81 | -8.60 | -8.31 | -12.96 |
| Balance Sheet | ||||
| Cash & Equivalents | 31.6 | 30.4 | 26.6 | 27.7 |
| Total Assets | 328.7 | 149.6 | 110.0 | 35.5 |
| Total Debt | 7.3 | 7.3 | 4.2 | 4.1 |
| Stockholders' Equity | 287.6 | 76.0 | 58.6 | 13 |
| Cash Flow | ||||
| Operating Cash Flow | (50.9) | (48.3) | (32.4) | (60.2) |
| Capital Expenditure | (5.3) | (3.4) | (0.4) | (0.8) |
| Free Cash Flow | (56.2) | (51.7) | (32.8) | (61.0) |